
-
Sinner denies beneficial treatment in doping scandal ahead of Rome return
-
Eurozone economy grows more than expected despite US tariff turmoil
-
Toulouse hooker Mauvaka out of Champions Cup semi
-
Germany's next finance minister, 'bridge-builder' Lars Klingbeil
-
Mehidy century puts Bangladesh in command against Zimbabwe
-
Steelmaker ArcelorMittal warns of uncertainty
-
Vietnam's Gen-Z captivated by 50-year-old military victory
-
Moroccan-based cardinal says Church does not need Francis 'impersonator'
-
US official tells UN top court 'serious concerns' over UNRWA impartiality
-
Jeep owner Stellantis suspends outlook over tariffs
-
New Zealand, Phillippines sign troops deal in 'deteriorating' strategic environment
-
Aston Martin limits US car imports due to tariffs
-
Pakistan says India planning strike as tensions soar over Kashmir
-
Australian triple-murder suspect allegedly cooked 'special' mushroom meal
-
Most stock markets rise despite China data, eyes on US reports
-
TotalEnergies profits drop as prices slide
-
Volkswagen says tariffs will dampen business as profit plunges
-
Jeep owner Stellantis suspends 2025 earnings forecast over tariffs
-
China's Shenzhou-19 astronauts return to Earth
-
French economy returns to thin growth in first quarter
-
Ex-Premier League star Li Tie loses appeal in 20-year bribery sentence
-
Belgium's green light for red light workers
-
Haliburton leads comeback as Pacers advance, Celtics clinch
-
Rahm out to break 2025 win drought ahead of US PGA Championship
-
Japan tariff envoy departs for round two of US talks
-
Djurgarden eyeing Chelsea upset in historic Conference League semi-final
-
Haliburton leads comeback as Pacers advance, Pistons stay alive
-
Bunker-cafe on Korean border paints image of peace
-
Tunics & turbans: Afghan students don Taliban-imposed uniforms
-
Asian markets struggle as trade war hits China factory activity
-
Norwegian success story: Bodo/Glimt's historic run to a European semi-final
-
Spurs attempt to grasp Europa League lifeline to save dismal season
-
Thawing permafrost dots Siberia with rash of mounds
-
S. Korea prosecutors raid ex-president's house over shaman probe: Yonhap
-
Filipino cardinal, the 'Asian Francis', is papal contender
-
Samsung Electronics posts 22% jump in Q1 net profit
-
Pietro Parolin, career diplomat leading race to be pope
-
Nuclear submarine deal lurks below surface of Australian election
-
China's manufacturing shrinks in April as trade war bites
-
Financial markets may be the last guardrail on Trump
-
Swedish journalist's trial opens in Turkey
-
Kiss says 'honour of a lifetime' to coach Wallabies at home World Cup
-
US growth figure expected to make for tough reading for Trump
-
Opposition leader confirmed winner of Trinidad elections
-
Snedeker, Ogilvy to skipper Presidents Cup teams: PGA Tour
-
Win or bust in Europa League for Amorim's Man Utd
-
Trump celebrates 100 days in office with campaign-style rally
-
Top Cuban dissidents detained after court revokes parole
-
Arteta urges Arsenal to deliver 'special' fightback against PSG
-
Trump fires Kamala Harris's husband from Holocaust board

Drug-resistant superbugs projected to kill 39 million by 2050
Infections of drug-resistant superbugs are projected to kill nearly 40 million people over the next 25 years, a global analysis predicted on Monday, as the researchers called for action to avoid this grim scenario.
Superbugs -- strains of bacteria or pathogens that have become resistant to antibiotics, making them much harder to treat -- have been recognised as a rising threat to global health.
The analysis has been billed as the first research to track the global impact of superbugs over time, and estimate what could happen next.
More than a million people died from the superbugs -- also called antimicrobial resistance (AMR) -- a year across the world between 1990 and 2021, according to the study in The Lancet journal.
Deaths among children under five from superbugs actually fell by more than 50 percent over the last three decades, the study said, due to improving measures to prevent and control infections for infants.
However when children now catch superbugs, the infections are much harder to treat.
And deaths of over-70s have surged by more than 80 percent over the same period, as an ageing population became more vulnerable to infection.
Deaths from infections of MRSA, a type of staph bacteria that has become resistant to many antibiotics, doubled to 130,000 in 2021 from three decades earlier, the study said.
- 'This threat is growing' -
The researchers used modelling to estimate that -- based on current trends -- the number of direct deaths from AMR would rise by 67 percent to reach nearly two million a year by 2050.
It will also play a role in a further 8.2 million annual deaths, a jump of nearly 75 percent, according to the modelling.
Under this scenario, AMR will have directly killed 39 million people over the next quarter century, and contributed to a total of 169 million deaths, it added.
But less dire scenarios are also possible.
If the world works to improve care for severe infections and access to antimicrobial drugs, it could save the lives of 92 million people by 2050, the modelling suggested.
"These findings highlight that AMR has been a significant global health threat for decades and that this threat is growing," study co-author Mohsen Naghavi of the US-based Institute of Health Metrics said in a statement.
The researchers looked at 22 pathogens, 84 combinations of drugs and pathogens, and 11 infectious syndromes such as meningitis. The study involved data from 520 million individual records across 204 countries and territories.
It was released ahead of a high-level AMR meeting at the United Nations scheduled for September 26.
Antimicrobial resistance is a natural phenomenon, but the overuse and misuse of antibiotics in humans, animals and plants has made the problem worse.
S.Gantenbein--VB